Therapeutic effects of the combined androgen blockade therapy versus luteinizing hormone-releasing hormone analog monotherapy in patients with hormone naïve metastatic prostate can...

por Narita, Takuma, Hatakeyama, Shingo, Narita, Shintaro, Takahashi, Masahiro, Sakurai, Toshihiko, Kawamura, Sadafumi, Hoshi, Senji, Shimoda, Jiro, Kawaguchi, Toshiaki, Ishidoya, Shigeto, Mitsuzuka, Koji, Arai, Yoichi, Ito, Akihiro, Tsuchiya, Norihiko, Habuchi, Tomonori, Ohyama, Chikara
Publicado 2021

Impact of pretreatment anemia on upfront abiraterone acetate therapy for metastatic hormone-sensitive prostate cancer: a multicenter retrospective study

por Okamoto, Teppei, Noro, Daisuke, Hatakeyama, Shingo, Narita, Shintaro, Mitsuzuka, Koji, Sakurai, Toshihiko, Kawamura, Sadafumi, Hoshi, Senji, Shimoda, Jiro, Tanaka, Toshikazu, Kawaguchi, Toshiaki, Ishidoya, Shigeto, Ito, Akihiro, Tsuchiya, Norihiko, Habuchi, Tomonori, Ohyama, Chikara
Publicado 2021

Prognostic significance of early changes in serum biomarker levels in patients with newly diagnosed metastatic prostate cancer

por Narita, Shintaro, Nomura, Kyoko, Hatakeyama, Shingo, Takahashi, Masahiro, Sakurai, Toshihiko, Kawamura, Sadafumi, Hoshi, Senji, Ishida, Masanori, Kawaguchi, Toshiaki, Ishidoya, Shigeto, Shimoda, Jiro, Sato, Hiromi, Mitsuzuka, Koji, Tochigi, Tatsuo, Tsuchiya, Norihiko, Ohyama, Chikara, Arai, Yoichi, Nagashima, Kengo, Habuchi, Tomonori
Publicado 2019

Changes in conditional net survival and dynamic prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy

por Narita, Shintaro, Nomura, Kyoko, Hatakeyama, Shingo, Takahashi, Masahiro, Sakurai, Toshihiko, Kawamura, Sadafumi, Hoshi, Senji, Ishida, Masanori, Kawaguchi, Toshiaki, Ishidoya, Shigeto, Shimoda, Jiro, Sato, Hiromi, Mitsuzuka, Koji, Tochigi, Tatsuo, Tsuchiya, Norihiko, Ohyama, Chikara, Arai, Yoichi, Nagashima, Kengo, Habuchi, Tomonori
Publicado 2019